Log in
Enquire now
‌

Trimtech Therapeutics

Developer of targeted protein degradation (TPD) for the treatment of neurodegenerative diseases.

OverviewStructured DataIssuesContributors

Contents

trimtechtherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Health technology
Health technology
Biotechnology
Biotechnology
Location
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
United Kingdom
United Kingdom
CEO
‌
Nicola Thompson
Number of Employees (Ranges)
1 – 10
Investors
Pfizer Venture Investments
Pfizer Venture Investments
‌
Start Codon
Cambridge Enterprise
Cambridge Enterprise
Dementia Discovery Fund
Dementia Discovery Fund
Eli Lilly
Eli Lilly
M Ventures
M Ventures
MP Healthcare Venture Management
MP Healthcare Venture Management
Cambridge Innovation Capital
Cambridge Innovation Capital
Founded Date
2023
Total Funding Amount (USD)
32,300,000
Latest Funding Round Date
March 5, 2025
Latest Funding Type
Seed
Seed

Other attributes

Latest Funding Round Amount (USD)
32,300,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Trimtech Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.